Recently, γ-secretase inhibitors aimed at blocking Notch receptor cleavage, including PF-03084014, MK-0752, and RO4929097, have been administered in clinical studies to treat locally advanced or metastatic pancreatic cancer; however, no significant remission has been observed13,14,15. Dual- or pan...